A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Indoximod (Primary) ; Docetaxel; Paclitaxel
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- Sponsors NewLink Genetics Corporation
- 02 Jun 2017 According to a NewLink Genetics Corporation media release, full results from this trial will be presented at an upcoming academic meeting.
- 02 Jun 2017 Primary endpoint (Progression Free Survival) has not been met, according to a NewLink Genetics Corporation media release.
- 12 Dec 2015 Preliminary results (n=65) presented at the 38th Annual San Antonio Breast Cancer Symposium.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History